U
Avivagen Inc. VIVXF
$0.00 $0.000.00% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2023 04/30/2023 01/31/2023 10/31/2022 07/31/2022
Net Income 32.23% 8.07% 18.37% 7.22% -9.71%
Total Depreciation and Amortization -39.47% -30.64% -33.58% -31.35% -26.05%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.60% 8.69% -40.52% -26.95% -31.12%
Change in Net Operating Assets 90.30% 334.88% 221.22% 201.46% 180.91%
Cash from Operations 81.55% 47.37% 42.06% 34.73% 11.91%
Capital Expenditure -- -- -- -- 135.71%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- 135.71%
Total Debt Issued -100.00% -199.70% -100.00% -100.00% -98.52%
Total Debt Repaid 99.17% 89.30% -377.45% -386.21% -418.38%
Issuance of Common Stock -90.48% 53.28% -3.17% -3.17% -11.82%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -152.86% 226.07% 158.46% 154.24% 148.17%
Cash from Financing -81.00% -35.32% -60.25% -63.27% -78.36%
Foreign Exchange rate Adjustments -101.93% -85.45% -93.42% -113.50% 113.40%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 81.58% 50.33% -339.43% -252.30% -242.78%